3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Neoplasms, Plasma Cell
1
Multiple Myeloma
1
Esophageal Neoplasms
1
COVID-19
1
Breast Neoplasms
1
Interventions
Dexamethasone
32
Cyclophosphamide
30
fludarabine phosphate
25
Melphalan
25
Busulfan
25
Bortezomib
21
Tacrolimus
20
Lenalidomide
19
Peripheral Blood Stem Cell Transplantation
18
Mycophenolic Acid
17
Whole-Body Irradiation
16
Antilymphocyte Serum
16
fludarabine
14
Calcium Dobesilate
13
Thalidomide
12
Filgrastim
12
Granulocyte Colony-Stimulating Factor
11
Methotrexate
10
pomalidomide
9
Cyclosporine
8
Radiotherapy
6
Etoposide
6
Cord Blood Stem Cell Transplantation
6
Surveys and Questionnaires
5
Stem Cell Transplantation
5
Rituximab
5
Methylprednisolone
5
sargramostim
4
carfilzomib
4
Sirolimus
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Neoplasms, Plasma Cell
×
Patient Reported Outcome Measures
×
Clear all
NCT05831787
2026-05-18
COSMIC
ASH Research Collaborative
Completed
201 enrolled
15 charts